Kuramo Capital Management

“Scribe Therapeutics...plans to raise up to $108m in an IPO...It's raised $121m from a16z, Avoro Ventures, Eli Lilly, OrbiMed, T. Rowe Price, Perceptive Advisors, Wellington Management, RA Capital Management, and Menlo Ventures.”

“A maker of male contraceptives, raised $92.5m in Series B funding co-led by BVF Partners and RA Capital Management, joined by GV (Google Ventures).”

“Nigeria's Bank of Industry appointed Kuramo Capital Management as fund manager of the DICE Fund of Funds, targeting a minimum capitalization of $170.6 million”